Addleshaw Goddard's Manchester corporate team has advised AIM-listed Premaitha Health plc, a leading international molecular diagnostics group, on its $5m extension of its investment agreement with Thermo Fisher Scientific.

The extension involves the issue to Thermo Fisher Scientific of warrants over 28,938,797 new ordinary shares exercisable at 10.725p with further warrants to be issued on a future date.

The AG team consisted of Roger Hart and Jamie Partridge, who advised Premaitha Health earlier this year, with regards to the placing of share with Harwood Capital.

AG's corporate remains a leader in the North West deals market, advising on a flurry over deals in a matters of weeks including, Foresight's investment into Mowgli Street Food and LDC's exit from Creative Engagement.